Literature DB >> 15221903

Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.

Rita Mariel Correa1, María Dolores Fellner, Lidia Virginia Alonio, Karina Durand, Angélica R Teyssié, María Alejandra Picconi.   

Abstract

There are two types of Epstein Barr virus (EBV): EBV-1 and EBV-2, distinguished by genomic polymorphism in the genes encoding the nuclear antigens (EBNA-2, -3A, -3B, -3C). Latent membrane protein 1 (LMP-1) is an EBV protein with known oncogenic properties. Different variants had been described; among them, a 30 base pair (bp) deletion (del-LMP-1) had been reported in benign and malignant pathologies, but there is little information about its frequency in healthy populations. The aim of this study was to determine the distribution of the EBV genotypes and the 30 bp deletion frequency, in EBV healthy carriers from Argentina. Analysis of EBNA-3C and LMP-1 genes were done by polymerase chain reaction (PCR) followed by Southern blot hybridization on DNA of peripheral blood mononuclear cells (PBMCs) from blood bank donors. EBV-1 was present in 75.9% of samples, EBV-2 in 14.6%, and co-infections with both types in 6.5%. The deleted LMP-1 variant was found in 7.4% of analyzed samples, corresponding 3.2% to deleted variant alone and 4.2% to co-infections with non-deleted form. The non-deleted variant was found in 64.6% whereas in the remaining 28%, no PCR product was detected. These results showed that EBV-1 was the more prevalent type in healthy carriers of Argentina, similar to reports from others countries. A predominance of the non-deleted LMP-1 variant was observed. The presence of co-infections with both types and variants demonstrated that healthy individuals may also harbor multiple EBV infections. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221903     DOI: 10.1002/jmv.20129

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1.

Authors:  Kyosuke Kanai; Yukio Satoh; Yuriko Saiki; Haruo Ohtani; Takeshi Sairenji
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

2.  Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.

Authors:  Mario Alejandro Lorenzetti; Magdalena Gantuz; Jaime Altcheh; Elena De Matteo; Paola Andrea Chabay; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 3.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

Review 4.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

5.  Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.

Authors:  Zeyi Deng; Takayuki Uehara; Hiroyuki Maeda; Masahiro Hasegawa; Sen Matayoshi; Asanori Kiyuna; Shinya Agena; Xiaoli Pan; Chunlin Zhang; Yukashi Yamashita; Minqiang Xie; Mikio Suzuki
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

6.  Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.

Authors:  Shuzhen Liu; Zhenzhen Zhao; Lu Han; Song Liu; Bing Luo
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

Review 7.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

8.  EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.

Authors:  Lassina Traore; Ouéogo Nikiema; Abdoul Karim Ouattara; Tegwindé Rébéca Compaore; Serge Théophile Soubeiga; Birama Diarra; Dorcas Obiri-Yeboah; Pegdwendé Abel Sorgho; Florencia Wendkuuni Djigma; Cyrille Bisseye; Albert Théophane Yonli; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-09-01       Impact factor: 2.576

9.  Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients

Authors:  Sadia Salahuddin; Jabbar Khan; Joharia Azhar; Christopher B. Whitehurst; Ishtiaq Qadri; Julia Shackelford; Joseph S Pagano; Dost Muhammad; Kristy L Richards
Journal:  Asian Pac J Cancer Prev       Date:  2018-11-29

10.  Molecular characterization of Epstein-Barr virus variants detected in the oral cavity of adolescents in Cali, Colombia

Authors:  Daniela Arturo-Terranova; Sebastián Giraldo-Ocampo; Andrés Castillo
Journal:  Biomedica       Date:  2020-05-01       Impact factor: 0.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.